Citation Impact

Citing Papers

The IASP classification of chronic pain for ICD-11: chronic primary pain
2018 Standout
Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review
2013 Standout
The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study
2010 Standout
The measurement of health-related quality of life (QOL) in paediatric clinical trials: a systematic review.
2004
Efficient diagnosis of suspected functional bowel disorders
2008
Functional Bowel Disorders
2006 Standout
Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
2008 Standout
NeuPSIG guidelines on neuropathic pain assessment
2010 Standout
Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity
2009 Standout
Differences in brain responses to visceral pain between patients with irritable bowel syndrome and ulcerative colitis
2005
Gut memories: Towards a cognitive neurobiology of irritable bowel syndrome
2011
Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi studies
2014 Standout
Bloating and Distention in Irritable Bowel Syndrome: The Role of Visceral Sensation
2008
The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results
2008 Standout
Bowel Habit Subtypes and Temporal Patterns in Irritable Bowel Syndrome: Systematic Review
2005
Functional Gastroduodenal Disorders
2006 Standout
Bowel Disorders
2016 Standout
Effect of a fermented milk containing Bifidobacterium animalis DN‐173 010 on the health‐related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double‐blind, controlled trial
2007
Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies
2009 Standout
Asian consensus on irritable bowel syndrome
2010
Basic and clinical aspects of gastrointestinal pain
2009
Management of the irritable bowel syndrome
2001
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome
2004
Extraintestinal Symptoms in Irritable Bowel Syndrome and Inflammatory Bowel Diseases: Nature, Severity, and Relationship to Gastrointestinal Symptoms
2003
Modulation of Intestinal Gas Dynamics in Healthy Human Volunteers by the 5-HT4Receptor Agonist Tegaserod
2006
Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain
2007 Standout
Abdominal Bloating in Employed Adults: Prevalence, Risk Factors, and Association With Other Bowel Disorders
2008
A Novel Delivery System of Peppermint Oil Is an Effective Therapy for Irritable Bowel Syndrome Symptoms
2015
Interpretation of Changes in Health-related Quality of Life
2003 Standout
Understanding the minimum clinically important difference: a review of concepts and methods
2007 Standout
Functional GI disorders: from animal models to drug development
2007
Transient receptor potential channels: targeting pain at the source
2008 StandoutNobel
An international urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunction
2009 Standout
The interplay between the intestinal microbiota and the brain
2012 Standout
Spinal and supraspinal modulation of visceral sensation: Figure 1
2000
The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders
2007 Standout
Irritable bowel syndrome
2016 Standout
Sleep dysfunction in patients with gastro‐oesophageal reflux disease: prevalence and response to GERD therapy, a pilot study
2004
Prospective Study of Motor, Sensory, Psychologic, and Autonomic Functions in Patients With Irritable Bowel Syndrome
2008
The Functional Gastrointestinal Disorders and the Rome III Process
2006 Standout
Evolving pathophysiologic models of functional gastrointestinal disorders
2002
A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome
2013 Standout
Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications?
2002 Standout
A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis
2004
Psychometric properties of the MOS (Medical Outcomes Study) Sleep Scale in patients with neuropathic pain
2006
Regulation of intestinal epithelial permeability by tight junctions
2012 Standout
Autonomic Functioning During REM Sleep Differentiates IBS Symptom Subgroups
2002
Health-Related Quality of Life in Patients Attending a Gastroenterology Outpatient Clinic: Functional Disorders Versus Organic Diseases
2006
Selective Role for TRPV4 Ion Channels in Visceral Sensory Pathways
2008
Life quality assessment among patients with atopic eczema
2005
Severity in Irritable Bowel Syndrome: A Rome Foundation Working Team Report
2011
Prevalence, Characteristics, and Impact of Bloating Symptoms in Patients With Irritable Bowel Syndrome
2009
The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus
2006 Standout
Epilepsy and quality of life in adults: A review of instruments
2005
Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes
2007 Standout
Protocol of the COSMIN study: COnsensus-based Standards for the selection of health Measurement INstruments
2006
Mechanisms of hypersensitivity in IBS and functional disorders
2007
Development, Validation, and Evaluation of a Pediatric Ulcerative Colitis Activity Index: A Prospective Multicenter Study
2007 Standout
Burnout and Medical Errors Among American Surgeons
2010 Standout
Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome as Well as Traditional Dietary Advice: A Randomized Controlled Trial
2015 Standout
A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea‐predominant irritable bowel syndrome
2003
Assessing the Minimally Clinically Significant Difference: Scientific Considerations, Challenges and Solutions
2005
An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome
2003
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Costs of Irritable Bowel Syndrome in the UK and US
2006
Symptomatic gastro‐oesophageal reflux, arousals and sleep quality in patients undergoing polysomnography for possible obstructive sleep apnoea
2004
Childhood Functional Gastrointestinal Disorders: Child/Adolescent
2006 Standout
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
2014 Standout
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
2018 Standout
Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials
2001
Sensation of bloating and visible abdominal distension in patients with irritable bowel syndrome
2001
AGA technical review on irritable bowel syndrome
2002 Standout
Irritable bowel syndrome subtypes according to bowel habit
2003
Towards a better understanding of abdominal bloating and distension in functional gastrointestinal disorders
2005
Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs
2004
Epidemiology of FGID symptoms in Japanese general population with reference to life style
2011
Prevalence and risk factors for abdominal bloating and visible distention: a population-based study
2008
Poor Reporting of Quality of Life Outcomes in Dermatology Randomized Controlled Clinical Trials
2007
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
2012 Standout
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis
2008 Standout
Managing Gastroesophageal Reflux Disease in Primary Care: The Patient Perspective
2005
The pros, cons, and many unknowns of probiotics
2019 Standout
Psychological Co-morbidity in Functional Gastrointestinal Disorders: Epidemiology, Mechanisms and Management
2012
Societal costs for irritable bowel syndrome – a population based study
2010
Self-Reported Food-Related Gastrointestinal Symptoms in IBS Are Common and Associated With More Severe Symptoms and Reduced Quality of Life
2013 Standout
Irritable bowel syndrome in the elderly: An overlooked problem?
2009
Costs of care for irritable bowel syndrome patients in a health maintenance organization
2001
Health‐related quality of life among persons with irritable bowel syndrome: a systematic review
2002
Irritable Bowel Syndrome
2015 Standout
Costs of care for irritable bowel syndrome patients in a health maintenance organization
2001
Effects of Probiotics, Prebiotics, and Synbiotics on Human Health
2017 Standout
SERT and TPH-1 mRNA expression are reduced in irritable bowel syndrome patients regardless of visceral sensitivity state in large intestine
2012
Chemotherapy for advanced gastric cancer
2017 Standout
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
2004 Standout
Issues for Statisticians in Conducting Analyses and Translating Results for Quality of Life End Points in Clinical Trials
2004
Global Epidemiology of Campylobacter Infection
2015 Standout
Randomized clinical trial: The effect of fermented milk with the probiotic cultures Lactobacillus acidophilus La-5® and Bifidobacterium BB-12® and Beneo dietary fibres on health-related quality of life and the symptoms of irritable bowel syndrome in adults
2016
Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa
2012 Standout
Randomized Controlled Trial of Cognitive–Behavioral Group Therapy for Irritable Bowel Syndrome in a Medical Setting
2003
Fructan and Free Fructose Content of Common Australian Vegetables and Fruit
2007
Osteoarthritis: an update with relevance for clinical practice
2011 Standout
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
2016 Standout

Works of Steve Fullerton being referenced

Symptoms and Visceral Perception in Patients With Pain-Predominant Irritable Bowel Syndrome
1999
Measurement of symptoms in irritable bowel syndrome clinical trials
1999
Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments
2001
Functional digestive disorders (FDD) in the year 2000-economic impact
2002
Sleep Disturbances in Clinic Patients With Functional Bowel Disorders
2000
Patient-Reported Outcomes: The Example of Health-Related Quality of Life—a European Guidance Document for the Improved Integration of Health-Related Quality of Life Assessment in the Drug Regulatory Process
2002
A patient based symptom questionnaire for use in irritable bowel syndrome (IBS)
2000
Rankless by CCL
2026